Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MK-0941 is an orally active and allosteric glucokinase activator, has potential in the treatment of type 2 diabetes.
Description | MK-0941 is an orally active and allosteric glucokinase activator, has potential in the treatment of type 2 diabetes. |
Targets&IC50 | GK (human recombinant):65 nM (EC50), GK (human recombinant):240 nM (EC50) |
Molecular Weight | 556.61 |
Formula | C22H28N4O9S2 |
CAS No. | 1137916-97-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 260 mg/mL (467.11 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MK-0941 1137916-97-2 Others MK0941 MK 0941 inhibitor inhibit